# Comparative Efficacy of Xiaopi Granules and Decoction in Triple-negative Breast Cancer: a Randomized Controlled Trial

> **NCT06154109** · PHASE2 · UNKNOWN · sponsor: **Zhiyu Wang** · enrollment: 90 (estimated)

## Conditions studied

- Triple Negative Breast Neoplasms

## Interventions

- **DRUG:** Xiaopi granules
- **DRUG:** Xiaopi decoction
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06154109
- **Lead sponsor:** Zhiyu Wang
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-11-25
- **Primary completion:** 2025-12-30
- **Final completion:** 2026-03-30
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2023-12-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06154109

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06154109, "Comparative Efficacy of Xiaopi Granules and Decoction in Triple-negative Breast Cancer: a Randomized Controlled Trial". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06154109. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*